STUDY OBJECTIVE: This study was designed to evaluate the peripheral muscle metabolic and structural characteristics in patients with advanced Chagas disease (ChD), and whether they were related with exercise performance. DESIGN: Cross-sectional study. SETTING: Outpatient cardiomyopathy clinic of a university hospital. PATIENTS AND METHODS: We studied 11 stage II patients, 8 stage III patients, and 11 healthy volunteers. All patients underwent exercise testing and peripheral muscle biopsies. The muscles were also studied in control subjects. Muscle biopsy specimens were analyzed for histochemical characteristics. In six patients, the muscle was studied ultrastructurally. RESULTS: The data demonstrate more glycolytic and less oxidative capacity of the peripheral muscle in patients with advanced ChD (increased proportion of type IIb fibers, increased proportion of fibers with low nicotinamide adenine dinucleotide diaphorase activity, high proportion of darkly stained fibers for alpha-glycerophosphate dehydrogenase activity, and lower levels of citrate synthase). Many capillaries in patients with ChD had an abnormal aspect: they were either closed or showed a thicker wall. The ultrastructural study also showed fiber atrophy and abnormal capillaries even in patients with normal functional capacity. Some muscle characteristics (enzyme activity, mean cross-sectional area of the fiber, and capillarity) related with exercise parameters (anaerobic threshold, and peak oxygen pulse). CONCLUSIONS: These findings indicate that patients with advanced ChD have decreased oxidative capacity and a shift to anaerobic metabolism in the skeletal muscle. They also suggest that muscular abnormalities are related to oxygen delivery, which is probably reduced in part by the abnormal muscle microvasculature. Those changes could affect oxygen extraction, and therefore exercise tolerance in these patients.
STUDY OBJECTIVE: This study was designed to evaluate the peripheral muscle metabolic and structural characteristics in patients with advanced Chagas disease (ChD), and whether they were related with exercise performance. DESIGN: Cross-sectional study. SETTING:Outpatientcardiomyopathy clinic of a university hospital. PATIENTS AND METHODS: We studied 11 stage II patients, 8 stage III patients, and 11 healthy volunteers. All patients underwent exercise testing and peripheral muscle biopsies. The muscles were also studied in control subjects. Muscle biopsy specimens were analyzed for histochemical characteristics. In six patients, the muscle was studied ultrastructurally. RESULTS: The data demonstrate more glycolytic and less oxidative capacity of the peripheral muscle in patients with advanced ChD (increased proportion of type IIb fibers, increased proportion of fibers with low nicotinamide adenine dinucleotide diaphorase activity, high proportion of darkly stained fibers for alpha-glycerophosphate dehydrogenase activity, and lower levels of citrate synthase). Many capillaries in patients with ChD had an abnormal aspect: they were either closed or showed a thicker wall. The ultrastructural study also showed fiber atrophy and abnormal capillaries even in patients with normal functional capacity. Some muscle characteristics (enzyme activity, mean cross-sectional area of the fiber, and capillarity) related with exercise parameters (anaerobic threshold, and peak oxygen pulse). CONCLUSIONS: These findings indicate that patients with advanced ChD have decreased oxidative capacity and a shift to anaerobic metabolism in the skeletal muscle. They also suggest that muscular abnormalities are related to oxygen delivery, which is probably reduced in part by the abnormal muscle microvasculature. Those changes could affect oxygen extraction, and therefore exercise tolerance in these patients.
Authors: Ghada S Hassan; Shankar Mukherjee; Fnu Nagajyothi; Louis M Weiss; Stefka B Petkova; Cecilia J de Almeida; Huan Huang; Mahalia S Desruisseaux; Boumediene Bouzahzah; Richard G Pestell; Chris Albanese; George J Christ; Michael P Lisanti; Herbert B Tanowitz Journal: Infect Immun Date: 2006-01 Impact factor: 3.441
Authors: Rômulo D Novaes; Arlete R Penitente; Reggiani V Gonçalves; André Talvani; Clóvis A Neves; Izabel R S C Maldonado; Antônio J Natali Journal: Int J Exp Pathol Date: 2011-07-08 Impact factor: 1.925
Authors: Nickson Melo De Morais; Micássio Fernandes De Andrade; Valéria Duarte De Almeida; Lara Candice Costa De Morais Leonez; Cléber Mesquita De Andrade; Christiane Medeiros Bezerra; Ellany Gurgel Cosme Do Nascimento; José Veríssimo Fernandes; Thales Allyrio Araújo De Medeiros Fernandes Journal: Biomed Rep Date: 2022-09-15
Authors: Sanivia A de Lima Pereira; Viviane O Severino; Narayane L M Kohl; Denise B R Rodrigues; Polyanna M Alves; Juliana T Clemente-Napimoga; Marlene A dos Reis; Vicente P A Teixeira; Marcelo H Napimoga Journal: Parasitol Res Date: 2009-06-10 Impact factor: 2.289
Authors: Guilherme Wesley Peixoto da Fonseca; Tania Garfias Macedo; Nicole Ebner; Marcelo Rodrigues Dos Santos; Francis Ribeiro de Souza; Charles Mady; Liliam Takayama; Rosa Maria Rodrigues Pereira; Wolfram Doehner; Stefan D Anker; Carlos Eduardo Negrão; Maria Janieire de Nazaré Nunes Alves; Stephan von Haehling Journal: ESC Heart Fail Date: 2020-08-28